These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 16330695)

  • 1. Cardiovascular disease in the developing world and its cost-effective management.
    Gaziano TA
    Circulation; 2005 Dec; 112(23):3547-53. PubMed ID: 16330695
    [No Abstract]   [Full Text] [Related]  

  • 2. Economic burden of physical inactivity: healthcare costs associated with cardiovascular disease.
    Oldridge NB
    Eur J Cardiovasc Prev Rehabil; 2008 Apr; 15(2):130-9. PubMed ID: 18391637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cardiovascular disease 2005--the global picture.
    Callow AD
    Vascul Pharmacol; 2006 Nov; 45(5):302-7. PubMed ID: 17074537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular disease and the UN Millennium Development Goals: time to move forward.
    Fuster V; Vedanthan R
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):593. PubMed ID: 18813335
    [No Abstract]   [Full Text] [Related]  

  • 5. Economic burden and the cost-effectiveness of treatment of cardiovascular diseases in Africa.
    Gaziano TA
    Heart; 2008 Feb; 94(2):140-4. PubMed ID: 18195120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Can we prevent cardiovascular diseases in low- and middle-income countries?
    Lenfant C
    Bull World Health Organ; 2001; 79(10):980-2; discussion 983-7. PubMed ID: 11693981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of costs related to cardiovascular disease among patients with atrial fibrillation in five European countries.
    Holstenson E; Ringborg A; Lindgren P; Coste F; Diamand F; Nieuwlaat R; Crijns H
    Europace; 2011 Jan; 13(1):23-30. PubMed ID: 20823043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The economics of cardiovascular disease in the United States.
    Chen J; Rizzo JA
    Crit Care Clin; 2012 Jan; 28(1):77-88, vi. PubMed ID: 22123100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can we predict cost of care in atrial fibrillation patients?
    Le Heuzey JY
    Europace; 2011 Jan; 13(1):1-2. PubMed ID: 20974753
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular disease in Europe.
    Rayner M; Allender S; Scarborough P;
    Eur J Cardiovasc Prev Rehabil; 2009 Aug; 16 Suppl 2():S43-7. PubMed ID: 19675436
    [No Abstract]   [Full Text] [Related]  

  • 11. [Cardiac stimulation in Africa: necessity must overcome doubt].
    Massoure PL; Roche N; Fourcade L
    Med Trop (Mars); 2011 Dec; 71(6):639-40. PubMed ID: 22393645
    [No Abstract]   [Full Text] [Related]  

  • 12. Developing sustainable cardiovascular care for low-resource nations.
    Madu EC; Tulloch-Reid E; Edwards P; Baugh DS; Kong BW
    J Am Coll Cardiol; 2009 Sep; 54(11):1038-9; author reply 1039. PubMed ID: 19729124
    [No Abstract]   [Full Text] [Related]  

  • 13. What price to pay? The cost of everything and the value of nothing.
    Ezekowitz JA
    Circulation; 2009 Jan; 119(3):368-70. PubMed ID: 19171866
    [No Abstract]   [Full Text] [Related]  

  • 14. The cost-effectiveness of implementing a new guideline for cardiovascular risk management in primary care in the Netherlands.
    Kok L; Engelfriet P; Jacobs-van der Bruggen MA; Hoogenveen RT; Boshuizen HC; Verschuren MW
    Eur J Cardiovasc Prev Rehabil; 2009 Jun; 16(3):371-6. PubMed ID: 19305351
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The epidemiological situation regarding cardiovascular diseases in the Lodz voivodship as a justification for prevention programmes].
    Maniecka-Bryła I; Bryła M; Stelmach W
    Ann Acad Med Stetin; 2005; 51 Suppl 1():97-103. PubMed ID: 16602434
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity, mortality and economic burden of renal impairment in cardiac intensive care.
    Chew DP; Astley C; Molloy D; Vaile J; De Pasquale CG; Aylward P
    Intern Med J; 2006 Mar; 36(3):185-92. PubMed ID: 16503954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stroke and cardiovascular diseases: the need for a global approach for prevention and drug development.
    Hilbrich L; Truelsen T; Yusuf S
    Int J Stroke; 2007 May; 2(2):104-8. PubMed ID: 18705961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cost of new therapies in cardiovascular care. Time for hope or despair for developing countries.
    Omeish AF
    Saudi Med J; 2007 May; 28(5):675-82. PubMed ID: 17457431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Costs of exacerbations of chronic obstructive pulmonary disease in primary and secondary care in 2007--results of multicenter Polish study].
    Jahnz-Rózyk K; Targowski T; From S
    Pol Merkur Lekarski; 2009 Mar; 26(153):208-14. PubMed ID: 19388534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global cost-effectiveness of cataract surgery.
    Lansingh VC; Carter MJ; Martens M
    Ophthalmology; 2007 Sep; 114(9):1670-8. PubMed ID: 17383730
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.